Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The factor VIIa/tissue factor complex

¹Pharma Division, F. Hoffmann-La Roche, Basle, Switzerland. David.Banner@Roche.Com

Thrombosis and Haemostasis

|July 1, 1997

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular and structural advances in tissue factor-dependent coagulation.

Trends in cardiovascular medicine·2011

Same author

Structure-based approaches in modern drug discovery research.

Ernst Schering Research Foundation workshop·2001

Same author

2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.

Journal of medicinal chemistry·2001

Same author

Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.

Journal of medicinal chemistry·2000

Same author

Enzymology. Not just an active site.

Nature·2000

Same author

Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors.

Journal of computer-aided molecular design·1999

Same journal

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Thrombosis and haemostasis·2026

Same journal

The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

Thrombosis and haemostasis·2026

Same journal

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026

Same journal

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Thrombosis and haemostasis·2026

Same journal

Methylglyoxal Promotes RBC-Driven Procoagulant Activity and Venous Thrombosis under Diabetes-Relevant Conditions.

Thrombosis and haemostasis·2026

Same journal

Management of Inferior Vena Cava Thrombosis: Guidance from the Italian Society for the Study of Haemostasis and Thrombosis.

Thrombosis and haemostasis·2026

See all related articles

The tissue factor:factor VIIa (TF:F.VIIa) complex initiates blood clotting. Its crystal structure reveals how TF and F.VIIa associate, aiding the development of targeted anticoagulants.

Area of Science:

Biochemistry
Structural Biology
Hematology

Background:

The tissue factor:factor VIIa (TF:F.VIIa) complex is crucial for initiating blood coagulation.
This complex is implicated in both normal hemostasis and thrombotic disorders.

Purpose of the Study:

To present the crystal structure of the TF:F.VIIa complex.
To provide a structural basis for understanding TF:F.VIIa interactions and guide anticoagulant development.

Main Methods:

X-ray crystallography was used to determine the structure of the TF:F.VIIa complex.

Main Results:

The crystal structure reveals the TF and F.VIIa molecules associated as a complex.
This structure offers a direct explanation for previously observed interactions within the complex.

Related Experiment Videos

Conclusions:

The determined TF:F.VIIa structure provides insights into the initiation of blood coagulation.
This structural information can be utilized to design more effective and specific anticoagulants.